Rupal S. Bhatt

2.7k citations

84 papers · 1.9k indexed · h-index 25

Impact in

Cancer Research top 5%
- Cancer Genomics and Diagnostics
- Cancer, Hypoxia, and Metabolism
Pulmonary and Respiratory Medicine top 2%
- Renal cell carcinoma treatment
- Prostate Cancer Treatment and Research

Papers in ⓘ

Cancer Research 30
- Cancer Genomics and Diagnostics 14
- Cancer, Hypoxia, and Metabolism 10
- Cancer, Lipids, and Metabolism 8
Pulmonary and Respiratory Medicine 61
- Renal cell carcinoma treatment 51
- Prostate Cancer Treatment and Research 9

Co-authors: Michael B. Atkins (39 shared papers)Sabina Signoretti (26 shared papers)Toni K. Choueiri (20 shared papers)David F. McDermott (24 shared papers)Toshifumi Tomoda (2 shared papers)Mary E. Hatten (2 shared papers)Vikas P. Sukhatme (8 shared papers)David C. Alsop (12 shared papers)
Journals: Journal of Clinical Oncology (22 papers)Clinical Cancer Research (10 papers)Cancer Research (7 papers)Cancer (4 papers)Clinical Genitourinary Cancer (3 papers)
Partner nations: United States Israel Canada

In The Last Decade

Rupal S. Bhatt

83 papers receiving 1.9k citations

Peers

Countries citing papers authored by Rupal S. Bhatt

Since Specialization

Citations

This map shows the geographic impact of Rupal S. Bhatt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rupal S. Bhatt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rupal S. Bhatt more than expected).

Fields of papers citing papers by Rupal S. Bhatt

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rupal S. Bhatt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rupal S. Bhatt. The network helps show where Rupal S. Bhatt may publish in the future.

Co-authors

The 25 scholars most cited alongside Rupal S. Bhatt, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Rupal S. Bhatt Line = papers co-authored together Rupal S. Bhatt links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 84 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Differential Expression of PD-L1 between Primary and Metastatic Sites in Clear-Cell Renal Cell Carcinoma Cancer Immunology Research ·Marcella Callea, Laurence Albigès, Mamta Gupta, Su–Chun Cheng, Elizabeth M. Genega, André P. Fay, Jiaxi Song, Ingrid Carvo, Rupal S. Bhatt, Michael B. Atkins, F. Stephen Hodi, Toni K. Choueiri, David F. McDermott, Gordon J. Freeman, Sabina Signoretti	2015	266
2	Angiotensin System Inhibitors and Survival Outcomes in Patients with Metastatic Renal Cell Carcinoma Clinical Cancer Research ·Rana R. McKay, Gustavo E. Rodriguez, Xun Lin, Marina D. Kaymakcalan, Ole‐Petter R. Hamnvik, Venkata Sabbisetti, Rupal S. Bhatt, Ronit Simantov, Toni K. Choueiri	2015	105
3	A Mouse Serine/Threonine Kinase Homologous to C. elegans UNC51 Functions in Parallel Fiber Formation of Cerebellar Granule Neurons Neuron ·Toshifumi Tomoda, Rupal S. Bhatt, Hidehito Kuroyanagi, Takuji Shirasawa, Mary E. Hatten	1999	104
4	KIR3DL3 Is an Inhibitory Receptor for HHLA2 that Mediates an Alternative Immunoinhibitory Pathway to PD1 Cancer Immunology Research ·Rupal S. Bhatt, Abdulla Berjis, Julie C. Konge, Kathleen M. Mahoney, Alyssa N. Klee, Samuel S. Freeman, Chun-Hau Chen, Opeyemi A. Jegede, Paul J. Catalano, Jean‐Christophe Pignon, Maura Sticco-Ivins, Baogong Zhu, Ping Hua, Jo Soden, Jie Zhu, David F. McDermott, Antonio R. Arulanandam, Sabina Signoretti, Gordon J. Freeman	2020	80
5	Discoidin domain receptor 1 functions in axon extension of cerebellar granule neurons Genes & Development ·Rupal S. Bhatt, Toshifumi Tomoda, Yin Fang, Mary E. Hatten	2000	75
6	Anti-S1P Antibody as a Novel Therapeutic Strategy for VEGFR TKI-Resistant Renal Cancer Clinical Cancer Research ·Zhang Liang, Xiaoen Wang, Andrea J. Bullock, Marcella Callea, Harleen Shah, Jiaxi Song, Kelli Moreno, Barbara Visentin, Douglas H. Deutschman, David C. Alsop, Michael B. Atkins, James W. Mier, Sabina Signoretti, Manoj Bhasin, Roger A. Sabbadini, Rupal S. Bhatt	2015	67
7	Resistance of Renal Cell Carcinoma to Sorafenib Is Mediated by Potentially Reversible Gene Expression PLoS ONE ·Liang Zhang, Manoj Bhasin, Rachel Schor-Bardach, Xiaoen Wang, Michael P. Collins, David J. Panka, Prabhakar Putheti, Sabina Signoretti, David C. Alsop, Towia A. Libermann, Michael B. Atkins, James W. Mier, S. Nahum Goldberg, Rupal S. Bhatt	2011	62
8	A phase 2 pilot trial of low‐dose, continuous infusion, or “metronomic” paclitaxel and oral celecoxib in patients with metastatic melanoma Cancer ·Rupal S. Bhatt, Jaime R. Merchan, Robert Parker, Hua‐Kang Wu, Liang Zhang, Virginia Seery, John V. Heymach, Michael B. Atkins, David F. McDermott, Vikas P. Sukhatme	2010	57
9	Plasma cell-free DNA variant analysis compared with methylated DNA analysis in renal cell carcinoma Genetics in Medicine ·Kathryn D. Lasseter, Amin H. Nassar, Lana Hamieh, Jacob E. Berchuck, Pier Vitale Nuzzo, Keegan Korthauer, Atul B. Shinagare, Barbara Ogórek, Rana R. McKay, Aaron R. Thorner, Gwo-Shu Mary Lee, David A. Braun, Rupal S. Bhatt, Matthew L. Freedman, Toni K. Choueiri, David J. Kwiatkowski	2020	51
10	Renal Cancer Resistance to Antiangiogenic Therapy Is Delayed by Restoration of Angiostatic Signaling Molecular Cancer Therapeutics ·Rupal S. Bhatt, Xiaoen Wang, Liang Zhang, Michael P. Collins, Sabina Signoretti, David C. Alsop, S. Nahum Goldberg, Michael B. Atkins, James W. Mier	2010	48
11	Phase 2 study of neoadjuvant docetaxel plus bevacizumab in patients with high‐risk localized prostate cancer Cancer ·Robert W. Ross, Matthew D. Galsky, Phil Febbo, Marc Barry, Jerome P. Richie, Wanling Xie, Fiona M. Fennessy, Rupal S. Bhatt, J. D. Hayes, Toni K. Choueiri, Clare M. Tempany, Philip W. Kantoff, Mary Ellen Taplin, William Oh	2012	47
12	A phase 2 study of the sphingosine‐1‐phosphate antibody sonepcizumab in patients with metastatic renal cell carcinoma Cancer ·Sumanta K. Pal, Harry A. Drabkin, James A. Reeves, John D. Hainsworth, Susan E. Hazel, Dario A. Paggiarino, Jon Wojciak, Gary Woodnutt, Rupal S. Bhatt	2016	45
13	Angiopoietin 2 Is a Potential Mediator of High-Dose Interleukin 2–Induced Vascular Leak Clinical Cancer Research ·Diana Gallagher, Rupal S. Bhatt, Samir M. Parikh, Parin Patel, Virginia Seery, David F. McDermott, Michael B. Atkins, Vikas P. Sukhatme	2007	43
14	Statins and survival outcomes in patients with metastatic renal cell carcinoma European Journal of Cancer ·Rana R. McKay, Xun Lin, Laurence Albigès, André P. Fay, Marina D. Kaymakcalan, Suzanne S Mickey, P. Peter Ghoroghchian, Rupal S. Bhatt, Samuel Kaffenberger, Ronit Simantov, Toni K. Choueiri, Daniel Yick Chin Heng	2015	40
15	Tumor Necrosis on Magnetic Resonance Imaging Correlates With Aggressive Histology and Disease Progression in Clear Cell Renal Cell Carcinoma Clinical Genitourinary Cancer ·Peter Beddy, Elizabeth M. Genega, Long Ngo, Nicole Hindman, Jesse Wei, Andrea J. Bullock, Rupal S. Bhatt, Michael B. Atkins, Iván Pedrosa	2013	39
16	Taxane resistance in prostate cancer is mediated by decreased drug-target engagement Journal of Clinical Investigation ·Ada Gjyrezi, Fang Xie, Olga Voznesensky, Prateek Khanna, Carla Calagua, Yang Bai, Justin W. Kung, Jim S. Wu, Eva Corey, Bruce Montgomery, Sandrine Macé, Diego A. Gianolio, Glenn J. Bubley, Steven P. Balk, Paraskevi Giannakakou, Rupal S. Bhatt	2020	38
17	Retrospective Analysis of the Safety and Efficacy of Interleukin-2 After Prior VEGF-targeted Therapy in Patients With Advanced Renal Cell Carcinoma Journal of Immunotherapy ·Daniel C. Cho, Igor Puzanov, Meredith M. Regan, Talya Schwarzberg, Virginia Seery, Mee-Young Lee, Vivian Liu, Rupal S. Bhatt, Henry Koon, James W. Mier, Jeffrey A. Sosman, Michael B. Atkins, David F. McDermott	2009	35
18	ACE2 abrogates tumor resistance to VEGFR inhibitors suggesting angiotensin-(1-7) as a therapy for clear cell renal cell carcinoma Science Translational Medicine ·Prateek Khanna, Hong Jie Soh, Chun-Hau Chen, Ruchi Saxena, Seema Amin, M. Naughton, Patrick Neset Joslin, Andrew M. Moore, Ziad Bakouny, C. O'Callaghan, Paul J. Catalano, Sabina Signoretti, Rana R. McKay, Toni K. Choueiri, Manoj Bhasin, Thomas Walther, Rupal S. Bhatt	2021	35
19	Cox-2 inhibition enhances the activity of sunitinib in human renal cell carcinoma xenografts British Journal of Cancer ·X Wang, L Zhang, A. O’Neill, Brittany Bahamón, David C. Alsop, J W Mier, S. Nahum Goldberg, Sabina Signoretti, Michael B. Atkins, Christopher G. Wood, Rupal S. Bhatt	2013	34
20	The Role of Angiopoietins as Potential Therapeutic Targets in Renal Cell Carcinoma Translational Oncology ·Xiaoen Wang, Andrea J. Bullock, Liang Zhang, Lin‐Hung Wei, Dongyin Yu, Kedar Mahagaokar, David C. Alsop, James W. Mier, Michael B. Atkins, Angela Coxon, Jon Oliner, Rupal S. Bhatt	2014	34

About Rupal S. Bhatt

Rupal S. Bhatt is a scholar working on Cancer Research, Pulmonary and Respiratory Medicine, Oncology, Molecular Biology and Aging, having authored 84 papers that have together received 1.9k indexed citations. Recurring topics across this work include Renal cell carcinoma treatment (51 papers), Renal and related cancers (23 papers), Cancer Genomics and Diagnostics (14 papers), Cancer Immunotherapy and Biomarkers (13 papers), Angiogenesis and VEGF in Cancer (11 papers), Cancer, Hypoxia, and Metabolism (10 papers), Prostate Cancer Treatment and Research (9 papers) and Cancer, Lipids, and Metabolism (8 papers). The work is most often cited by research in Cancer Research (553 citations), Pulmonary and Respiratory Medicine (848 citations), Oncology (652 citations), Molecular Biology (917 citations) and Immunology and Allergy (64 citations). Rupal S. Bhatt has collaborated with scholars based in United States, Israel and Canada. Frequent co-authors include Michael B. Atkins, Sabina Signoretti, Toni K. Choueiri, David F. McDermott, Toshifumi Tomoda, Mary E. Hatten, Vikas P. Sukhatme, David C. Alsop, Marcella Callea and Jiaxi Song. Their work appears in journals such as Journal of Clinical Oncology, Clinical Cancer Research, Cancer Research, Cancer and Clinical Genitourinary Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact